Literature DB >> 21894044

Application of beta regression to analyze ischemic stroke volume in NINDS rt-PA clinical trials.

Christopher J Swearingen1, Barbara C Tilley, Robert J Adams, Zoran Rumboldt, Joyce S Nicholas, Dipankar Bandyopadhyay, Robert F Woolson.   

Abstract

BACKGROUND AND
PURPOSE: Ischemic stroke lesion volumes have proven difficult to analyze due to the extremely skewed shape of their underlying distribution. We introduce an extension of generalized linear models, beta regression, as a possible method of modeling extremely skewed distributions as evidenced in ischemic stroke lesion volumes.
METHODS: The NINDS rt-PA clinical trials measured ischemic stroke lesion volume as a secondary trial outcome. Three-month lesion volumes from these trials were analyzed using beta regression. A multi-variable regression model associating explanatory variables with ischemic stroke lesion volumes was constructed using accepted model building strategies and compared with the previously published volumetric analysis.
RESULTS: Beta regression produced a similar model when compared to the previous analysis published by the study group. All previously identified variables of importance were detected in the model building process. The age by treatment interaction described in previous studies was also found in this analysis, confirming the strong effect age has on stroke outcomes. Further, a treatment effect was elicited in terms of odds ratios, yielding a previously unknown quantification of the effect of rt-PA on lesion volumes.
CONCLUSIONS: Beta regression proved adept in modeling ischemic stroke lesions and offered the interpretation of covariates in terms of odds ratios. Beta regression is seen as a legitimate alternative to analyze ischemic stroke volumes.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21894044      PMCID: PMC3186717          DOI: 10.1159/000330375

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  20 in total

Review 1.  The revised CONSORT statement for reporting randomized trials: explanation and elaboration.

Authors:  D G Altman; K F Schulz; D Moher; M Egger; F Davidoff; D Elbourne; P C Gøtzsche; T Lang
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

2.  Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. NINDS; The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.

Authors: 
Journal:  Stroke       Date:  2000-12       Impact factor: 7.914

3.  Measurements of acute cerebral infarction: a clinical examination scale.

Authors:  T Brott; H P Adams; C P Olinger; J R Marler; W G Barsan; J Biller; J Spilker; R Holleran; R Eberle; V Hertzberg
Journal:  Stroke       Date:  1989-07       Impact factor: 7.914

4.  Is diffusion imaging appearance an independent predictor of outcome after ischemic stroke?

Authors:  J M Wardlaw; S L Keir; M E Bastin; P A Armitage; A K Rana
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

5.  Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? A multivariable analysis.

Authors:  V N Thijs; M G Lansberg; C Beaulieu; M P Marks; M E Moseley; G W Albers
Journal:  Stroke       Date:  2000-11       Impact factor: 7.914

6.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

7.  A rapid, reliable, and valid method for measuring infarct and brain compartment volumes from computed tomographic scans.

Authors:  P D Lyden; R Zweifler; Z Mahdavi; L Lonzo
Journal:  Stroke       Date:  1994-12       Impact factor: 7.914

Review 8.  Stroke.

Authors:  Geoffrey A Donnan; Marc Fisher; Malcolm Macleod; Stephen M Davis
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321

9.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

10.  The clinical significance of diffusion-weighted MR imaging in infratentorial strokes.

Authors:  S T Engelter; S G Wetzel; E W Radue; M Rausch; A J Steck; P A Lyrer
Journal:  Neurology       Date:  2004-02-24       Impact factor: 9.910

View more
  7 in total

1.  Multi-tiered analysis of brain injury in neonates with congenital heart disease.

Authors:  Sarah B Mulkey; Christopher J Swearingen; Maria S Melguizo; Michael L Schmitz; Xiawei Ou; Raghu H Ramakrishnaiah; Charles M Glasier; G Bradley Schaefer; Adnan T Bhutta
Journal:  Pediatr Cardiol       Date:  2013-05-08       Impact factor: 1.655

2.  Nutlin-3 treatment spares cisplatin-induced inhibition of bone healing while maintaining osteosarcoma toxicity.

Authors:  Kimo C Stine; Elizabeth C Wahl; Lichu Liu; Robert A Skinner; Jaclyn VanderSchilden; Robert C Bunn; Corey O Montgomery; James Aronson; David L Becton; Richard W Nicholas; Christopher J Swearingen; Larry J Suva; Charles K Lumpkin
Journal:  J Orthop Res       Date:  2016-02-26       Impact factor: 3.494

3.  Cisplatin inhibits bone healing during distraction osteogenesis.

Authors:  Kimo C Stine; Elizabeth C Wahl; Lichu Liu; Robert A Skinner; Jacquelyn Vanderschilden; Robert C Bunn; Corey O Montgomery; Larry J Suva; James Aronson; David L Becton; Richard W Nicholas; Christopher J Swearingen; Charles K Lumpkin
Journal:  J Orthop Res       Date:  2013-11-20       Impact factor: 3.494

4.  Tracking the changes in synchrony of the electrophysiological activity as the uterus approaches labor using magnetomyographic technique.

Authors:  Rathinaswamy B Govindan; Eric Siegel; Samantha Mckelvey; Pam Murphy; Curtis L Lowery; Hari Eswaran
Journal:  Reprod Sci       Date:  2014-10-27       Impact factor: 3.060

5.  Studying the Interplay Between Apolipoprotein E and Education on Cognitive Decline in Centenarians Using Bayesian Beta Regression.

Authors:  Qingyan Xiang; Stacy Lynn Andersen; Thomas T Perls; Paola Sebastiani
Journal:  Front Genet       Date:  2021-01-08       Impact factor: 4.599

Review 6.  Thrombolysis for acute ischaemic stroke.

Authors:  Joanna M Wardlaw; Veronica Murray; Eivind Berge; Gregory J del Zoppo
Journal:  Cochrane Database Syst Rev       Date:  2014-07-29

7.  A Monte Carlo simulation study comparing linear regression, beta regression, variable-dispersion beta regression and fractional logit regression at recovering average difference measures in a two sample design.

Authors:  Christopher Meaney; Rahim Moineddin
Journal:  BMC Med Res Methodol       Date:  2014-01-24       Impact factor: 4.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.